Surgery Partners (SGRY) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
9 Nov, 2026Executive summary
Amended merger agreement provides for HealthSpan Partners, an affiliate of Bon Secours Mercy Health, to acquire the business in an all-cash deal valued at up to ~$6.0B enterprise value, following an unsolicited competing proposal.
The transaction is expected to close in Q1 2027, subject to stockholder approval, regulatory approvals and customary closing conditions.
The combined platform is expected to unite more than 200 locations across 30 states and ~5,000 affiliated physicians with HealthSpan Partners’ healthcare network.
Voting matters and shareholder proposals
Stockholders will be asked to approve the proposed acquisition; the transaction also requires regulatory approvals and other customary closing conditions.
A definitive proxy statement and Schedule 13E-3 are planned; stockholders were urged to review them and related SEC filings before voting.
Board of directors and corporate governance
The Board and Special Committee reviewed the unsolicited proposal, received Nov. 3 and updated Nov. 8, with independent financial and legal advisers.
The Special Committee unanimously recommended the amended HealthSpan agreement, and the Board approved it, citing the competing proposal’s longer or uncertain timeline, greater regulatory risk and lack of requested protections.
The Board reaffirmed its recommendation for the amended HealthSpan agreement.
Latest events from Surgery Partners
- Board backs HealthSpan’s amended ~$6.0B all-cash deal, targeting a Q1 2027 close.SGRY
Proxy filing - Same-facility growth partly offset Idaho divestiture drag; merger amended to $25 per share.SGRY
Q3 2026 - Revised merger offers $25 per share plus up to $1.61 in delay payments.SGRY
Proxy filing - Proposed $5.7B all-cash sale targets Q1 2027 close, pending approvals.SGRY
Proxy filing - HealthSpan Partners deal targets a Q1 2027 close, pending approvals and a shareholder vote.SGRY
Proxy filing - HealthSpan Partners’ ~$5.7B cash acquisition awaits shareholder and regulatory approval.SGRY
Proxy filing - A $23.50-per-share acquisition combines cash consideration with Bain Capital’s equity rollover.SGRY
Proxy filing - Q2 2026 revenue rose 2.7%, guidance reaffirmed, and Idaho Falls divestiture to generate $795M.SGRY
Q2 2026 - Q3 revenue rose 14.3% and Adjusted EBITDA 21.9%, led by high acuity cases and acquisitions.SGRY
Q3 2024